Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis

BMC Cardiovascular Disorders

Susan M Begelman¹  Joan R Jacobs¹  Laura K Chu¹  Diana M Felici¹  Pavel Napalkov¹ 

[1]Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA

关键词: Catheter-related thrombosis;    Catheter-related complication;    Catheters;    Bloodstream infections;    Adverse events;   

Others  :  856788
DOI  :  10.1186/1471-2261-13-86

 received in 2013-01-03, accepted in 2013-09-26,  发布年份 2013

【 摘 要 】

Background

Central venous catheter (CVC) and hemodialysis (HD) catheter usage are associated with complications that occur during catheter insertion, dwell period, and removal. This study aims to identify and describe the incidence rates of catheter-related complications in a large patient population in a United States-based health care claims database after CVC or HD catheter placement.

Methods

Patients in the i3 InVision DataMart^® health care claims database with at least 1 CVC or HD catheter insertion claim were categorized into CVC or HD cohorts using diagnostic and procedural codes from the US Renal Data System, American College of Surgeons, and American Medical Association’s Physician Performance Measures. Catheter-related complications were identified using published diagnostic and procedural codes. Incidence rates (IRs)/1000 catheter-days were calculated for complications including catheter-related bloodstream infections (CRBSIs), thrombosis, embolism, intracranial hemorrhage (ICH), major bleeding (MB), and mechanical catheter–related complications (MCRCs).

Results

Thirty percent of the CVC cohort and 54% of the HD cohort had catheter placements lasting <90 days. Catheter-related complications occurred most often during the first 90 days of catheter placement. IRs were highest for CRBSIs in both cohorts (4.0 [95% CI, 3.7-4.3] and 5.1 [95% CI, 4.7-5.6], respectively). Other IRs in CVC and HD cohorts, respectively, were thrombosis, 1.3 and 0.8; MCRCs, 0.6 and 0.7; embolism, 0.4 and 0.5; MB, 0.1 and 0.3; and ICH, 0.1 in both cohorts. Patients with cancer at baseline had significantly higher IRs for CRBSIs and thrombosis than non-cancer patients. CVC or HD catheter–related complications were most frequently seen in patients 16 years or younger.

Conclusions

The risk of catheter-related complications is highest during the first 90 days of catheter placement in patients with CVCs and HD catheters and in younger patients (≤16 years of age) with HD catheters. Data provided in this study can be applied toward improving patient care.

【 授权许可】

   
2013 Napalkov et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Akoh JA: Vascular access infections: epidemiology, diagnosis, and management. Curr Infect Dis Rep 2011, 13:324-332.
• [2]Lorente L, Henry C, Martín MM, Jiménez A, Mora ML: Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 2005, 9:R631-R635. BioMed Central Full Text
• [3]O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee (HICPAC) Clinical Infectious Diseases: Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52:1087-1099.
• [4]Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant 2008, 23:3219-3226.
• [5]Vazquez MA: Vascular access for dialysis: recent lessons and new insights. Curr Opin Nephrol Hypertens 2009, 18:116-121.
• [6]Lok CE: Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol 2007, 2:1043-1053.
• [7]Chan MR: Hemodialysis central venous catheter dysfunction. Semin Dial 2008, 21:516-521.
• [8]Nakazawa N: Infectious and thrombotic complications of central venous catheters. Semin Oncol Nurs 2010, 26:121-131.
• [9]Boersma RS, Jie KS, Verbon A, van Pampus EC, Schouten HC: Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 2008, 19:433-442.
• [10]US Renal Data System: USRDS 2006 annual data report: atlas of end-stage renal disease in the United States (Appendix A, p. 248–249; p. 261, Tables A and B). Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006. http://www.usrds.org/2006/pdf/13_appendices_06.pdf webcite
• [11]US Renal Data System: USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States (Appendix A, pp. 272 and 288, Tables A and B).. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD; 2007. http://www.usrds.org/2007/pdf/13_app_07.pdf webcite
• [12]US Renal Data System: USRDS 2008 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States (Appendix A, pp. 211 and 223, Tables 11a.b and 11a.c). Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008. http://www.usrds.org/2008/pdf/V2_Appendices_2008.pdf webcite
• [13]Levy I, Bendet M, Samra Z, Shalit I, Katz J: Infectious complications of peripherally inserted central venous catheters in children. Pediatr Infect Dis J 2010, 29:426-429.
• [14]Pinon M, Bezzio S, Tovo PA, Fagioli F, Farinasso L, Calabrese R, Marengo M, Giacchino M: A prospective 7-year survey on central venous catheter-related complications at a single pediatric hospital. Eur J Pediatr 2009, 168:1505-1512.
• [15]Hammarskjold F, Wallen G, Malmvall BE: Central venous catheter infections at a county hospital in Sweden: a prospective analysis of colonization, incidence of infection and risk factors. Acta Anaesthesiol Scand 2006, 50:451-460.
• [16]Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara : Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer 2006, 14:153-160.
• [17]McGee DC, Gould MK: Preventing complications of central venous catheterization. N Engl J Med 2003, 348:1123-1133.
• [18]Merrer J, De Jonghe B, Golliot F, Lefrant J-Y, Raffy B, Barre E, Rigaud J-P, Casciani D, Misset B, Bosquet C, Outin H, Brun-Buisson C, Nitenberg G, for the French Catheter Study Group in Intensive Care: Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized trial. JAMA 2001, 286:700-707.
• [19]Parienti JJ, Thirion M, Mégarbane B, Souweine B, Ouchikhe A, Polito A, Forel J-M, Marqué S, Misset B, Airapetian N, Daurel C, Mira J-P, Ramakers M, du Cheyron D, Le Coutour X, Daubin C, Charbonneau P, for Members of the Cathedia Study Group: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008, 299:2413-2422.
• [20]Hadaway LC: Reopen the pipeline for IV therapy. Nursing 2005, 35:54-60.
• [21]Lee AY, Levine MN, Butler G, Webb C, Costantini L, Gu C, Julian JA: Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006, 24:1404-1408.
• [22]Hryszko T, Brzosko S, Mazerska M, Malyszko J, Mysliwiec M: Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. A prospective study. Nephron Clin Pract 2004, 96:c43-c47.
• [23]Sharma A, Zilleruelo G, Abitbol C, Montane B, Strauss J: Survival and complications of cuffed catheters in children on chronic hemodialysis. Pediatr Nephrol 1999, 13:245-248.
• [24]Cortelezzi A, Moia M, Falanga A, Pogliani EM, Agnelli G, Bonizzoni E, Gussoni G, Barbui T, Mannucci PM, CATHEM Study Group: Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol 2005, 129:811-817.
• [25]Johnson EM, Saltzman DA, Suh G, Dahms RA, Leonard AS: Complications and risks of central venous catheter placement in children. Surgery 1998, 124:911-916.
• [26]Di Iorio B, Lopez T, Procida M, Marino P, Valente V, Iannuzziello F, Bombini A, Bellizzi V, Terracciano V, Bagnato C, Casino F, Gaudiano V, Mostacci D, Santarsia G, Biscione R, Caputo A, Ferlan G, Lauria MA, Marinaro G, Molinari R, Sanicandro D, Lotito MA, Plastino G, Carretta P: Successful use of central venous catheter as permanent hemodialysis access: 84-month follow-up in Lucania. Blood Purif 2001, 19:39-43.
• [27]US Census Bureau, Population Division: Table 1: Annual Estimates of the Population for the United States, Regions, States, and Puerto Rico: April 1, 2000 to July 1, 2007 (NST-EST2007-01). 2012. http://www.census.gov/popest/data/historical/2000s/vintage_2007/index.html webcite
• [28]World Health Organization: International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Geneva, Switzerland: World Health Organization; 2008.
• [29]Preskitt JT, Bothe A Jr, Harris JA: CPT changes in 2004. Bull Am Coll Surg 2004, 89:21-24.
• [30]American Medical Association Physician Consortium for Performance Improvement: Prevention of catheter-related bloodstream infections (CRBSI) – central venous catheter insertion protocol (Physician performance measures and related data specifications). Chicago, IL: American Medical Association; 2007.
• [31]de Jonge RC, Polderman KH, Gemke RJ: Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med 2005, 6:329-339.
• [32]Oguzkurt L, Tercan F, Torun D, Yildirim T, Zumrutdal A, Kizilkilic O: Impact of short-term hemodialysis catheters on the central veins: a catheter venographic study. Eur J Radiol 2004, 52:293-299.
• [33]Power A, Singh S, Ashby D, Hamady M, Moser S, Gedroyc W, Taube D, Duncan N, Cairns T: Translumbar central venous catheters for long-term haemodialysis. Nephrol Dial Transplant 2010, 25:1588-1595.
• [34]Zingg W, Cartier-Fassler V, Walder B: Central venous catheter-associated infections. Best Pract Res Clin Anaesthesiol 2008, 22:407-421.
• [35]Baskin JL, Pui CH, Wilimas JA, Metzger ML, Ribeiro RC, Howard SC: Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009, 374:159-169.
• [36]Lordick F, Hentrich M, Decker T, Hennig M, Pohlmann H, Hartenstein R, Peschel C: Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study. Br J Haematol 2003, 120:1073-1078.
• [37]Yacopetti N: Central venous catheter-related thrombosis: a systematic review. J Infus Nurs 2008, 31:241-248.
• [38]Abdelkefi A, Ben Romdhane N, Krias A, Chelli M, Torjman L, Ladeb S, Ben Othman T, Lakhal A, Guermazi S, Ben Hassen A, Ladeb F, Ben Abdeladhim A: Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplant recipients. Bone Marrow Transplant 2005, 36:885-889.
• [39]Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV: The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 2004, 89:201-206.
• [40]Tesselaar ME, Ouwerkerk J, Nooy MA, Rosendaal FR, Osanto S: Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer 2004, 40:2253-2259.
• [41]Boersma RS, Hamulyak K, Cate HT, Schouten HC: Congenital thrombophilia and central venous catheter-related thrombosis in patients with cancer. Clin Appl Thromb Hemost 2010, 6:643-649.
• [42]Goetz AM, Wagener MM, Miller JM, Mudder RR: Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998, 19:842-845.
• [43]Parienti JJ, du Cheyron D, Timsit JF, Traoré O, Kalfon P, Mimoz O, Mermel LA: Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults. Crit Care Med 2012, 40:1627-1634.